Bundles vs Enzyme Finance: Which index platform fits? (2026)

Bundles and Enzyme Finance both sit in the index category, but they address different needs. Bundles turns several assets into one ERC-20 token, with automatic rebalancing intended to maintain target allocations. Its curated options include different styles of bundle, and users can also create and manage their own. It is focused on Ethereum.

Enzyme is infrastructure for creating and administering tokenized funds and strategies, rather than simply a ready-made basket product. Onyx supports fund issuance and administration, Blue is for managing strategies across protocols and assets, and Myso offers on-chain options. Enzyme lists Ethereum, Polygon and Arbitrum. Its product mix and compliance tooling point more toward institutions and asset managers than casual DeFi users. In short, Bundles makes basket ownership simpler; Enzyme offers managers a broader toolkit for building and operating investment products.

Neither publishes enough detail here to make a direct fee comparison. Bundles does not publish a fee table or specific rebalancing, management, performance, entry or exit charges. It says BUN is used to pay rebalancing and swap fees, and that a single transaction can save gas compared with buying assets separately. Normal Ethereum gas costs still apply.

Enzyme does not publish specific fee levels here either. Its homepage directs Onyx issuers to a pricing page, while individual vault managers may set management or performance fees. Network gas also applies when using a vault. Before committing funds, check the costs shown for the particular bundle or vault and include transaction costs in your comparison. Do not assume that one platform is cheaper because its fee schedule is less visible.

Bundles has no audits listed. It also does not describe custody details, admin keys or incident history, so its smart-contract risk is not independently documented publicly. The project says users hold bundle tokens in their own wallets, but that does not remove contract or asset risk. Every bundle must include at least 5% BUN, and baskets may include wrapped or tokenized assets such as WBTC, wstETH and PAXG, which add risks beyond the protocol itself. Its TVL is relatively small, and its track record is short.

Enzyme has two audits listed, and its homepage says it is SOC 2 certified and has operated for more than eight years. The auditors, audit scope and dates are not specified here. Enzyme users still face smart-contract risk and the risks of the chosen strategy and any third-party protocols it uses. Compliance tools do not guarantee that a particular fund meets legal requirements. Neither platform makes these risks disappear; assess the relevant product and jurisdiction before using either.

Bundles is the more focused product. Its core appeal is one-token access to a basket, automatic rebalancing and a choice between curated and user-managed bundles. That can reduce the manual work of managing allocations, but it also ties each bundle to its underlying holdings and to BUN's required share. Its single supported chain is Ethereum.

Enzyme offers more kinds of infrastructure: white-label fund tools through Onyx, strategy management through Blue, and options through Myso. Blue supports strategies across more than 30 protocols and hundreds of assets, according to the product description. Enzyme also describes whitelisting, AML/CTF requirements and transaction monitoring. These capabilities suit organizations building products or managing strategies, but they may be unnecessary for someone who simply wants a token basket. Its wider listed chain coverage is Ethereum, Polygon and Arbitrum.

Choose Bundles if you want a relatively straightforward Ethereum token basket with automatic rebalancing, and you are comfortable with its small TVL, required BUN exposure and lack of listed audits. Review each bundle's holdings and costs before buying; a single token does not remove the risks of the assets inside it.

Choose Enzyme if you are an asset manager, institution or other user looking for tools to issue tokenized funds or manage on-chain strategies across multiple chains. It has substantially higher TVL and more documented security signals, including two audits listed, but specific fees and audit details are not published here. Its product range is broader, yet that does not make it the simpler option for casual users. For an individual seeking a managed basket, Bundles is the more direct fit; for building or operating investment products, Enzyme is the stronger match.